Interactions of PVT1 and CASC11 on prostate cancer risk in African Americans
Cancer Epidemiology, Biomarkers & Prevention | Apr 02, 2019
Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study
The Lancet Respiratory Medicine | Apr 02, 2019
The role of access to a regular primary care physician in mediating immigration-based disparities in colorectal screening: Application of multiple mediation methods
Cancer Epidemiology, Biomarkers & Prevention | Apr 02, 2019
PAM50 molecular intrinsic subtypes in the Nurses’ Health Study cohorts
Cancer Epidemiology, Biomarkers & Prevention | Apr 02, 2019
Low expression of the androgen-induced tumor suppressor gene PLZF and lethal prostate cancer
Cancer Epidemiology, Biomarkers & Prevention | Apr 02, 2019
Darolutamide in nonmetastatic, castration-resistant prostate cancer
New England Journal of Medicine | Apr 01, 2019
Changes in practice among physicians with malpractice claims
New England Journal of Medicine | Apr 01, 2019
Prevalence of germline mutations associated with cancer risk in patients with intraductal papillary mucinous neoplasms
Gastroenterology | Apr 01, 2019
Biomarkers associated with response to regorafenib in patients with hepatocellular carcinoma
Gastroenterology | Apr 01, 2019